In addition, Goldman Sachs has raised India back to an Overweight position, expecting a 14% upside with an end-2026 NIFTY ...

As of Monday, November 10, Mesa Laboratories, Inc.’s MLAB share price has surged by 5.38%, which has investors questioning if ...

Motilal Oswal recommended Neutral rating on Divis Laboratories with a target price of Rs 6925 in its research report dated November 08, 2025.

It started as a quiet murmur on social media, read Instagram: beauty enthusiasts showing off glossy, plush lips, crediting ...

Despite success with injectable drugs pharma companies are investing heavily in tablets, long considered the holy grail of ...

HOUSTON, Nov. 11, 2025 /PRNewswire/ — Salarius Pharmaceuticals, Inc. (“Salarius” or the “Company”) (NASDAQ: SLRX) today announced the pricing of an underwritten public offering for gross proceeds of ...

Crinetics Pharmaceuticals' stock has surged after FDA approval of Palsonify for acromegaly. Click here to read the latest ...

This multitasking formula blends vitamin C, ferulic acid and tranexamic acid to energise the skin, boost collagen synthesis and fade ... It’s proof that high-performance peptide technology doesn’t ...

Fewer jars on the shelf. Better science under the cap. Many classics still work. Yet a single plant oil is drawing serious attention for firmness, glow, ...

Solid-phase peptide synthesis is indispensable for routinely preparing linear peptides up to 40 amino acids. However, chain insolubility and aggregation continue to hamper this method, reducing ...

The U.S. Peptide Therapeutics Retail Market offers growth opportunities driven by increased healthcare spending and demand ...